Robin Mansukhani

Robin Mansukhani is the CEO and Co-Founder of Deciduous Therapeutics. Prior to this, they served as an advisor at Therini Bio, Inc. and as an Entrepreneur in Residence at New York University. Robin has a passion for helping others and promoting entrepreneurship. Robin is excited to continue growing Deciduous Therapeutics and making a positive impact on the lives of others.

Robin Mansukhani has a B.S. in Biochemistry from Case Western Reserve University.

Some individuals on their team include Janice Lansita - Toxicology Lead, Leah Makley - Chief Operating Officer, and Rachel Hatano - Chief of Staff.